IFI44L and PI3 transcript levels are robust classifiers to discriminate bacterial from viral infection in UC-OI, and measuring its levels appears to be predictive infection progression and treatment outcome in UC patients over time. This evidence concerns the gene IFI44L and viral infectious disease.